Also known as Hodgkin's disease, Hodgkin's lymphoma (HL) is a cancer of the white blood cells, or lymphocytes. Characterized by swelling in the lymph nodes, HL is most frequently treated with chemotherapy, especially in its later, more advanced stages.
Like many cancers, the spread of Hodgkin's lymphoma can be measured on a scale of four stages, with Stage I being least severe and Stage 4 being most. The following are characteristics of the four stages:
While a diagnosis of Stage IV (Four) Hodgkin's lymphoma is a very serious diagnosis, HL remains one of the most treatable of cancers. It responds well to treatment, whether radiation or chemotherapy. About 60 percent of Stage IV patients will be cured of the disease.
Using the staging of the disease is not, however, always a reliable method of assessing survivability. An international effort in 1998 produced a list of seven factors that are intended to provide a more accurate measure of an individual person's likelihood of responding to treatment.
The scale is based on five-year freedom from progression (FFP), or the percentage of patients whose disease has been successfully halted within five years. Patients with zero factors have an 84 percent FFP. Each of the following factors reduces the 5-year FFP by seven percent:
The reliability of the criteria declines with more than five factors, so for five or more factors, the 5-year FFP is said to be 42 percent.
The Hodgkin's lymphoma Stage IV prognosis is therefore reasonably positive. As one of the "best" cancers to have, Hodgkin's lymphoma is less likely to pose a threat to a patient's life, even in its more advanced stages, than many other diseases.
Photo: Pixabay